U.S. Chamber 2020 International IP Index

Since the first edition of the U.S. Chamber International Intellectual Property Index (IP Index) in 2012, countless new life-changing technologies, life-saving medicines, and life-enhancing creative works have improved our human experience. We can do so much now that we couldn’t do before.

And it’s all because innovators everywhere strove toward the art of the possible. They recognized that the possible isn’t an immoveable fixture; it’s elastic, it’s evolving, and it’s constantly bounding forward. The possible isn’t easy or plain; it’s hard-fought and speculative.

The 2020 U.S. Chamber International IP Index creates a template for economies that aspire to become 21st century, knowledge-based economies through more effective IP protection. With a robust IP ecosystem, economies can unleash the Art of the Possible, taking the ideas and creations of the mind and transforming them into the next generation of technologies, medicines, and creative works that enrich our lives. Economies large and small and developed and developing can leverage effective IP standards to foster innovation and creativity, attract greater foreign direct investment (FDI), and stimulate economic and global competitiveness.


In its eighth edition, the Index maps the IP ecosystem in 53 global economies, representing over 90% of global GDP.

The Index evaluates the IP framework in each economy across 50 unique indicators which industry believes represent economies with the most effective IP systems. The indicators create a snapshot of an economies overall IP ecosystem and span nine categories of protection: patents, copyrights, trademarks, design rights, trade secrets, commercialization of IP assets, enforcement, systemic effciency, and membership and ratification of international treaties.


Key Findings

  • IP remained at the crux of the China trade dispute. The United States and China signed a Phase One trade agreement on January 15, 2020. The Phase Two agreement is expected to focus on IP reforms and will create an opportunity to continue to improve IP protection globally.
  • Recent free trade agreements (FTAs) have failed to strengthen global IP standards, and future agreements must do more to raise the bar for IP protection.
  • Developed and developing economies alike are undermining biopharmaceutical innovation, which reduces access to life-saving medicines and technologies and is the wrong approach to address health care costs.
  • Several emerging markets made progress towards implementing a range of pro-IP measures in order to attract investment, though challenges remain.


Global Innovation Policy Center @globalIPcenter 8h

For almost three decades, the U.S. Chamber – and GIPC – has enjoyed a strong partnership with @SenRobPortman. Our statement on his retirement announcement here. https://t.co/5oY1DSDLEL

Reply Retweet Favorite

Subscribe for updates from GIPC